These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11419884)

  • 1. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.
    Feldman M; Jialal I; Devaraj S; Cryer B
    J Am Coll Cardiol; 2001 Jun; 37(8):2036-41. PubMed ID: 11419884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women.
    Feldman M; Cryer B; Rushin K; Betancourt J
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):53-7. PubMed ID: 11190906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose aspirin: selective inhibition of rectal dialysis thromboxane B2 in healthy volunteers.
    Cole AT; Filipowicz B; Hyman-Taylor P; Hawkey CJ
    Aliment Pharmacol Ther; 1994 Oct; 8(5):521-6. PubMed ID: 7865644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units.
    Hauth J; Sibai B; Caritis S; VanDorsten P; Lindheimer M; Klebanoff M; MacPherson C; Landon M; Paul R; Miodovnik M; Meis P; Dombrowski M; Thurnau G; Walsh S; McNellis D; Roberts JM
    Am J Obstet Gynecol; 1998 Nov; 179(5):1193-9. PubMed ID: 9822499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
    Tohgi H; Tamura K; Kimura B; Kimura M; Suzuki H
    Stroke; 1988 Jun; 19(6):700-3. PubMed ID: 3376161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension.
    Louden KA; Broughton Pipkin F; Symonds EM; Tuohy P; O'Callaghan C; Heptinstall S; Fox S; Mitchell JR
    Br J Obstet Gynaecol; 1992 May; 99(5):371-6. PubMed ID: 1622907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin.
    Louden KA; Broughton Pipkin F; Heptinstall S; Fox SC; Tuohy P; O'Callaghan C; Mitchell JR; Symonds EM
    Br J Obstet Gynaecol; 1994 Mar; 101(3):203-8. PubMed ID: 8193093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease.
    Maree AO; Curtin RJ; Dooley M; Conroy RM; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2005 Oct; 46(7):1258-63. PubMed ID: 16198840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes.
    Basili S; Tanzilli G; Raparelli V; Calvieri C; Pignatelli P; Carnevale R; Dominici M; Placanica A; Arrivi A; Farcomeni A; Barillà F; Mangieri E; Violi F
    Circ Cardiovasc Interv; 2014 Aug; 7(4):577-84. PubMed ID: 25074252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calprotectin and platelet aggregation in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Pareek M; Kristensen SD; Hvas AM
    PLoS One; 2015; 10(5):e0125992. PubMed ID: 25970343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial.
    Hauth JC; Goldenberg RL; Parker CR; Copper RL; Cutter GR
    Am J Obstet Gynecol; 1995 Aug; 173(2):578-84. PubMed ID: 7645637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury.
    Lee M; Cryer B; Feldman M
    Ann Intern Med; 1994 Feb; 120(3):184-9. PubMed ID: 8273981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
    N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.
    Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB
    J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors.
    Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA
    J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot trial of the effects of low-dose acetylsalicylic acid on platelet thromboxane B2 production.
    Janssen PL; Akkerman JW; Hollman PC; van Staveren WA; Zwaginga JJ; Katan MB
    Eur J Clin Nutr; 1995 May; 49(5):365-70. PubMed ID: 7664723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.